ImmuneSensor Therapeutics, Inc.
Biotechnology company · Dallas, Texas, United States
ImmuneSensor Therapeutics, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2022.
ImmuneSensor Therapeutics at a glance
What does ImmuneSensor Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $10 million sold (2022).
Frequently asked questions about ImmuneSensor Therapeutics
Where is ImmuneSensor Therapeutics headquartered?
ImmuneSensor Therapeutics, Inc. is headquartered in Dallas, Texas, United States.
What does ImmuneSensor Therapeutics do?
ImmuneSensor Therapeutics, Inc. is a biotechnology company.
When was ImmuneSensor Therapeutics founded?
The earliest incorporation on record for ImmuneSensor Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- OncoNano Medicine, Inc.Dallas, Texas, United States
- Taysha Gene Therapies, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Stingray Therapeutics, Inc.Dallas, Texas, United States
- Qualia Oto, Inc.Dallas, Texas, United States
- EtiraRX, Inc.Dallas, Texas, United States
- CG Oncology, Inc.Dallas, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences